Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV001663785 | SCV001879437 | uncertain significance | not provided | 2020-12-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002539658 | SCV003558508 | uncertain significance | Inborn genetic diseases | 2021-11-12 | criteria provided, single submitter | clinical testing | The c.4916G>C (p.G1639A) alteration is located in exon 15 (coding exon 15) of the PKD1 gene. This alteration results from a G to C substitution at nucleotide position 4916, causing the glycine (G) at amino acid position 1639 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |